Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: data from the PROGRESS study.

Abstract

Chronic kidney disease (CKD) is associated with a high risk of cardiovascular disease, but evidence regarding the effectiveness of interventions to reduce that risk is lacking. The Perindopril Protection against Recurrent Stroke Study (PROGRESS) study enrolled 6105 participants with cerebrovascular disease and randomly allocated them to perindopril-based… (More)

Topics

6 Figures and Tables

Cite this paper

@article{Perkovic2007ChronicKD, title={Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: data from the PROGRESS study.}, author={Vlado Perkovic and Toshiharu Ninomiya and Hisatomi Arima and Martin Gallagher and Meg J. Jardine and Alan Cass and Bruce Neal and Stephen MacMahon and John Chalmers}, journal={Journal of the American Society of Nephrology : JASN}, year={2007}, volume={18 10}, pages={2766-72} }